Team reports on the blind spots in drug research funding

How much money does the public sector invest in the development of medicines? The Austrian Institute for Health Technology Assessment (AIHTA) aims to shed light on this issue and uses antibiotics as an example. Without public subsidies and grants, there are no new products.

Leave A Comment

Your email address will not be published. Required fields are marked *